NIPT test

Verifi Prenatal Test The Forefront of Prenatal Screening

Clinical Background
• The verifi Test from Illumina represents a major advance in prenatal testing, providing highly sensitive and specific answers about fetal chromosomal health without the risks associated with invasive procedures, such as amniocentesis or chorionic villus sampling (CVS).

• The verifi Prenatal Test is screens for multiple fetal chromosomal aneuploidies using one tube of maternal blood. The test offers the following benefits:

  • Accurate - Lowest failure rate (0.1%)

  • Reliable - Directly analyzes cell-free fetal and maternal DNA; High detection rate

  • Easy - Noninvasive blood draw, just one tube (7–10 ml); test as early as 10 weeks gestational age (8 weeks of fetal age as determined by date of conception) with no limitations regarding ethnicity, BMI, ART or egg donor cases

  • Fast - Results reported to partner laboratory in 3 - 5 business days after sample receipt (time to report may vary based on partner laboratory providing the test)

Indications for ordering the test
Result Interpretation
Specimen and Transport Temperature